ALDH2 Mediated Ferroptosis Regulation in Ischemia–Reperfusion Injury
Journal of Cellular and Molecular Medicine · 2026
DOI: 10.1111/jcmm.71072 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Liang Han und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for Rehabilitation Medicine, Department of Anesthesiology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medic…. Hauptthemen laut MEDLINE: Ferroptosis, Aldehyde Dehydrogenase, Mitochondrial, Reperfusion Injury. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 167 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ischemia–reperfusion injury (IRI) is a common complication in diverse clinical settings, including myocardial infarction, stroke, organ transplantation and major surgery. Its pathological core lies in the metabolic disruption caused by blood flow cessation, followed by oxidative stress, inflammatory cascades and cell death upon reperfusion. Aldehyde dehydrogenase 2 (ALDH2), a mitochondrial enzyme best known for its role in aldehyde detoxification, has emerged as an important endogenous protective factor in IRI. ALDH2 limits the accumulation of toxic lipid peroxidation products, preserves mitochondrial function and attenuates oxidative and inflammatory damage in multiple organs. In parallel, ferroptosis, an iron‐dependent form of regulated cell death driven by lipid peroxidation, has been increasingly recognised as a key execution pathway in IRI. Increasing evidence suggests a close intersection between ALDH2 and ferroptosis. This review aims to systematically summarise the interplay between ALDH2 and ferroptosis in IRI, further explore their involvement in other forms of regulated cell death and highlight their points of convergence. Collectively, available data suggest that targeting ALDH2 may represent a promising strategy for limiting ferroptosis and reducing tissue damage in IRI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Rehabilitation Medicine, Department of Anesthesiology, Zhejiang Provincial People's Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, China.
- Research Institute of Anesthesiology and Perioperative Medicine, Hangzhou Medical College, Zhejiang, Hangzhou, China.
ORCID-Profile: Wen Zhai
Zitieren
APA
Han, L., & Zhai, W. (2026). ALDH2 Mediated Ferroptosis Regulation in Ischemia–Reperfusion Injury. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71072
Vancouver
Han L, Zhai W. ALDH2 Mediated Ferroptosis Regulation in Ischemia–Reperfusion Injury. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71072
BibTeX
@article{Han2026,
author = {Han, Liang and Zhai, Wen},
title = {ALDH2 Mediated Ferroptosis Regulation in Ischemia–Reperfusion Injury},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
doi = {10.1111/jcmm.71072}
}
EUVIMED